Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,893
Total Claims
$801K
Drug Cost
506
Beneficiaries
$1,583
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+58%
Opioid rate vs peers
3.5% vs 2.2% avg
+12%
Cost per patient vs peers
$1,583 vs $1,411 avg
+20%
Brand preference vs peers
12.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
3.5%
Opioid Rate
314
Opioid Claims
$5,009
Opioid Cost
4.1%
Long-Acting Rate
Brand vs Generic
Brand: 1,129 claims · $634K
Generic: 7,692 claims · $163K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 63 | $87K |
| Rivaroxaban | 77 | $74K |
| Dulaglutide | 46 | $62K |
| Apixaban | 69 | $59K |
| Budesonide/Formoterol Fumarate | 67 | $34K |
| Tirzepatide | 20 | $28K |
| Sitagliptin Phosphate | 36 | $28K |
| Semaglutide | 21 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 41 | $24K |
| Dapagliflozin Propanediol | 14 | $19K |
| Fluticasone/Umeclidin/Vilanter | 20 | $13K |
| Mirabegron | 16 | $13K |
| Tiotropium Bromide | 16 | $13K |
| Insulin Detemir | 16 | $12K |
| Insulin Aspart | 16 | $9,401 |
Prescribing Profile
Patient Profile
72
Avg Age
70%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About